Your browser doesn't support javascript.
Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study.
Ferdenzi, Camille; Bousquet, Christophe; Aguera, Pierre-Emmanuel; Dantec, Morgane; Daudé, Christelle; Fornoni, Lesly; Fournel, Arnaud; Kassan, Aurélien; Mantel, Marylou; Moranges, Maëlle; Moussy, Erwan; Richard Ortegón, Stéphane; Rouby, Catherine; Bensafi, Moustafa.
  • Ferdenzi C; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Bousquet C; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Aguera PE; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Dantec M; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Daudé C; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Fornoni L; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Fournel A; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Kassan A; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Mantel M; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Moranges M; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Moussy E; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Richard Ortegón S; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Rouby C; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
  • Bensafi M; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, University Claude Bernard Lyon 1, CH Le Vinatier, Bât. 462 Neurocampus, 95 boulevard Pinel, 69675 Bron Cedex, France.
Chem Senses ; 462021 01 01.
Article in English | MEDLINE | ID: covidwho-1258753
ABSTRACT
Although olfactory disorders (OD) are among the most significant symptoms of COVID-19, recovery time from COVID-19-related OD and their consequences on the quality of life remain poorly documented. We investigated the characteristics and behavioral consequences of COVID-19-related OD using a large-scale study involving 3111 French respondents (78% women) to an online questionnaire over a period of 9 months covering different epidemic waves (from 8 April 2020 to 13 January 2021). In the patients who subjectively recovered from COVID-19-related OD (N = 609), recovery occurred on average after 16 days and most of the time within 1 month ("normal" recovery range); 49 subjectively recovered in 1-2.5 months, and several cases took up to 6.5 months. Among the patients with ongoing OD (N = 2502), 974 were outside the "normal" recovery range (persistent OD) and reported OD for 1-10 months. Developing a persistent OD was more likely with increasing age and in women and was more often associated with parosmia and phantosmia. The deleterious impact of COVID-19-related OD on the quality of life was significantly aggravated by OD duration and was more pronounced in women. Because persistent OD is not infrequent after COVID-19, has deleterious consequences on the quality of life, and receives few solutions from the health practitioners, it would be beneficial to implement screening and treatment programs to minimize the long-term behavioral consequences of COVID-19-related OD.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Olfaction Disorders Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Chemse

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Olfaction Disorders Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Chemse